Want to see NDSN full AI Analyst Report?
EBITDA by Segment
Analyzes earnings before interest, taxes, depreciation, and amortization for each segment, highlighting profitability and operational efficiency across different business areas.Nordson’s profitability mix has shifted away from legacy industrial coating toward higher-growth, higher-margin businesses: Industrial Precision now drives the bulk of EBITDA, ATS is re-accelerating on semiconductor/electronics demand, and Medical & Fluid is climbing despite a temporary regulatory start-up drag. Corporate costs remain a steady negative. Management’s record backlog, raised guidance and exceptional cash conversion support continued EBITDA upside, but input-cost inflation, lower-than-normal incremental EBITDA conversion and one-time charges constrain near-term margin expansion.
Date | Corporate | Industrial Precision | Medical & Fluid | Advanced Technology | Industrial Coating |
|---|---|---|---|---|---|
Jul 31, 2026 | -$21.40M | $129.90M | $88.29M | $65.69M | $0.00 |
Apr 30, 2026 | -$15.91M | $123.58M | $79.19M | $48.33M | $0.00 |
Jan 31, 2026 | -$10.13M | $110.31M | $70.21M | $32.60M | $0.00 |
Oct 31, 2025 | -$12.09M | $137.42M | $87.66M | $42.76M | $0.00 |
Jul 31, 2025 | -$16.32M | $130.13M | $83.15M | $41.55M | $0.00 |
Apr 30, 2025 | -$12.45M | $113.55M | $76.54M | $39.52M | $0.00 |
Jan 31, 2025 | -$11.78M | $112.78M | $64.33M | $22.77M | $0.00 |
Oct 31, 2024 | -$14.98M | $143.19M | $72.26M | $40.62M | $0.00 |
Jul 31, 2024 | -$15.27M | $135.17M | $61.93M | $26.31M | $0.00 |
Apr 30, 2024 | -$15.04M | $131.75M | $62.56M | $24.15M | $0.00 |